-+ 0.00%
-+ 0.00%
-+ 0.00%

Incyte Corporation Unveils Promising Phase 3 Clinical Trial Results for Povorcitinib at EADV 2025 Congress

Reuters·09/10/2025 11:30:26

Please log in to view news